Apix­a­ban CAS 503612-47-3

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions andamp ; Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

503612-47-3

Name

Apix­a­ban

Syn­onyms

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxamid [Ger­man] [ACD/IUPAC Name] 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide [ACD/IUPAC Name] 1-(4-Méthoxyphényl)-7-oxo-6-[4-(2-oxo-1-pipéridinyl)phényl]-4,5,6,7-tétrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide [French] [ACD/IUPAC Name] 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide 1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]- [ACD/​Index Name] 503612-47-3 [RN] Apix­a­ban [INN] [USAN] [Wiki] apix­a­banum [Latin] [INN] BMS 562247-01 [503612-47-3] 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide 1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-; 3-car­boxylic acid amide 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide 205-514-0 [EINECS] 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide Apix­a­ban (USAN/INN) apix­a­banum BMS-562247|Eliquis® BMS562247-01 Eliquis [Trade name] Eliquis® GG2 MFCD00002708 [MDL num­ber] MFCD11977295 [MDL num­ber] OO 1750000 UNII-3Z9Y7UW­C1J

Mol­e­c­u­lar Structure

SMILES

COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N

Std­InChI

InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)

Std­InChIKey

QNZCBYK­­SOI­H­PEH-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C25H25N5O4

Mol­e­c­u­lar Weight

459.50

EINECS

205-514-0

MDL Number

MFCD00002708

Prop­er­ties

Appear­ance

White pow­der

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Apix­a­ban CAS 503612-47-3

Stan­dard

Enter­prise stan­dard

GMP

LCF­DA

Basic Patent Situation

US expiry date	20230203
EU expiry date	20260517
JP expiry date	2026818

Iden­ti­fi­ca­tion Methods

HNMR/HPLC

Puri­ty

98%min

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the phar­ma­ceu­ti­cal API, pri­ma­ry pre­ven­tion of throm­bin gen­er­a­tion and throm­bus for­ma­tion.

Links

This prod­uct is devel­oped by our RD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​a​p​i​x​a​b​a​n​-​c​a​s​-​5​0​3​6​1​2​-​4​7​-3/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).